NCT04096222 Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients Status UNKNOWN Phase N/A
NCT04078698 Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine Status COMPLETED Phase NA
NCT04041544 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject Status UNKNOWN Phase PHASE1
NCT04015596 Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS Status TERMINATED Phase PHASE4
NCT04007939 Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC) Status COMPLETED Phase N/A
NCT04005456 Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design Status COMPLETED Phase NA
NCT03956953 Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT03953768 VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems Status RECRUITING Phase NA
NCT03907540 Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 Status COMPLETED Phase PHASE1
NCT03899298 Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Status NOT_YET_RECRUITING Phase PHASE1
NCT03885375 Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients Status UNKNOWN Phase N/A
NCT03884400 Distribution of Biospecimens From Biorepositories/Biobanks for Research Use Status WITHDRAWN Phase N/A
NCT03870828 Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study Status NOT_YET_RECRUITING Phase N/A
NCT03848962 Collection and Distribution of Biospecimens for Novel Research Uses Status RECRUITING Phase N/A
NCT03793270 Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT03790293 Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial Status COMPLETED Phase PHASE3